Sutro Biopharma, founded in South San Francisco, California, is a clinical-stage company dedicated to the discovery and development of precisely designed cancer therapeutics. Their core mission is to improve patient outcomes through innovative antibody drug conjugates and multi-specific antibody-based treatments. Sutro Biopharma focuses on creating effective therapies for cancer, serving the pharmaceutical industry across the United States.

Notable affiliated individuals include experienced scientists and industry leaders who drive the company's research and development efforts. Sutro Biopharma has secured significant investments from prominent venture capital firms, aiding in their growth and innovation. Key achievements include advancing multiple drug candidates into clinical trials, demonstrating promising efficacy and safety profiles. Sutro Biopharma's impact lies in its potential to revolutionize cancer treatment, offering new hope to patients through cutting-edge biopharmaceutical solutions.